Yumiko Kimura Selected Research

25-methoxyporicoic acid A

10/2009

Anti-tumor-promoting effects of 25-methoxyporicoic acid A and other triterpene acids from Poria cocos.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumiko Kimura Research Topics

Disease

19	Neoplasms (Cancer) 01/2020 - 02/2002
13	Carcinogenesis 01/2020 - 01/2004
4	Inflammation (Inflammations) 01/2009 - 02/2002
4	Neuroblastoma 04/2008 - 08/2005
3	Experimental Melanoma 01/2010 - 01/2009
2	Infections 01/2017 - 01/2009
2	Melanoma (Melanoma, Malignant) 08/2010 - 12/2006
2	Pulmonary Tuberculosis 09/2007 - 07/2007
2	Leukemia 12/2006 - 08/2005
1	Lymphadenopathy 09/2022
1	Arthritis (Polyarthritis) 09/2022
1	Chickenpox 09/2022
1	Fever (Fevers) 09/2022
1	Herpes Zoster 09/2022
1	Coinfection 09/2022
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Pneumonia (Pneumonitis) 01/2017
1	Lung Neoplasms (Lung Cancer) 02/2011
1	Bacteremia 01/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2008
1	Liver Failure 09/2007
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 07/2007
1	Colonic Neoplasms (Colon Cancer) 12/2006
1	Rheumatoid Arthritis 09/2006

Drug/Important Bio-Agent (IBA)

9	anthraceneIBA 06/2012 - 10/2005
8	TriterpenesIBA 10/2009 - 03/2002
7	AcidsIBA 10/2009 - 03/2002
3	ChalconesIBA 02/2012 - 01/2006
3	Melanins (Melanin)IBA 01/2010 - 01/2009
3	Peroxynitrous Acid (Peroxynitrite)IBA 01/2009 - 10/2005
3	xanthoangelolIBA 04/2008 - 08/2005
3	Chalcone (Benzalacetophenone)IBA 04/2008 - 08/2005
3	Pharmaceutical PreparationsIBA 10/2007 - 08/2005
3	Epstein-Barr virus early antigenIBA 09/2006 - 02/2002
2	SteroidsIBA 01/2008 - 09/2007
2	isobavachalconeIBA 10/2007 - 01/2006
2	Caspase 3 (Caspase-3)IBA 10/2007 - 08/2005
2	cucurbitaneIBA 08/2007 - 02/2002
2	GlycosidesIBA 12/2006 - 02/2002
2	lupaneIBA 09/2006 - 03/2002
1	Rifabutin (Ansamycin)FDA Link 09/2022
1	AutoantibodiesIBA 09/2022
1	Ethambutol (Myambutol)FDA LinkGeneric 09/2022
1	InterferonsIBA 09/2022
1	Clarithromycin (Biaxin)FDA LinkGeneric 09/2022
1	CaspasesIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Trypan Blue FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017
1	lupulonIBA 06/2012
1	6-prenylnaringeninIBA 06/2012
1	5-deprenyllupulonol CIBA 06/2012
1	poricotriol AIBA 02/2011
1	Amino Acids FDA Link 08/2010
1	alpha-MSHIBA 01/2010
1	25-methoxyporicoic acid AIBA 10/2009
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 01/2009
1	azadirachtin BIBA 01/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2008
1	diphenyl (biphenyl)IBA 10/2007
1	Caspase 9IBA 10/2007
1	BromidesIBA 10/2007
1	EstersIBA 05/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2007
1	SterolsIBA 02/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2006
1	oleananeIBA 09/2006
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 09/2006
1	cembraneIBA 09/2006
1	tirucallaneIBA 09/2006
1	ursaneIBA 09/2006
1	DiterpenesIBA 09/2006
1	DiarylheptanoidsIBA 05/2006
1	acerogenin MIBA 05/2006
1	monascinIBA 10/2005
1	euscaphic acidIBA 10/2005
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2004
1	betulonic acidIBA 03/2002
1	betulinIBA 03/2002
1	CarcinogensIBA 03/2002
1	LupanesIBA 03/2002

Therapy/Procedure

3	Therapeutics 01/2017 - 12/2006
1	Aftercare (After-Treatment) 09/2022
1	Catheters 01/2009
1	Drug Therapy (Chemotherapy) 04/2008
1	Pneumonectomy (Lung Volume Reduction) 07/2007
1	Oral Administration 10/2005